Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.
Hofstra
Julia M
JM
Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. J.Hofstra@nier.umcn.nl
Wetzels
Jack F M
JF
D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000139:chemically induced; D011379:Prognosis; D016896:Treatment Outcome
D000477:Alkylating Agents; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide